Evidence map›Paper›PMID 40967185›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2025

Diagnostic performance of magnetic resonance imaging and targeted biopsy results in men with indwelling urinary catheters A propensity score-matched study.

Tomer Bashi, Adi Kidron, Ziv Savin, Amihay Nevo, Sophie Barnes, Ofer Yossepowitch, Roy Mano, Snir Dekalo

Abstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomer BashiDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Adi KidronDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ziv SavinDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Amihay NevoDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sophie BarnesDepartment of Radiology, Tel Aviv Sourasky Medical Center, Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Ofer YossepowitchDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Roy ManoDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Snir DekaloDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe sought to evaluate multiparametric magnetic resonance imaging (mpMRI) findings and biopsy results in men with an indwelling catheter undergoing prostate cancer screening. mpMRI is central to the evaluation of prostate cancer. Little is known about the effect of an indwelling urinary catheter on prostate mpMRI findings and the results of subsequent biopsies.

methodsWe retrospectively reviewed 5820 mpMRI exams performed from 2017-2023. Forty-eight patients underwent mpMRI with an indwelling urinary catheter. Using propensity score matching, patients were matched 1:1 for age, pre-biopsy prostate-specific antigen (PSA), and prostate volume. Clinical characteristics, mpMRI findings, and targeted biopsy results were compared between the groups.

resultsAfter propensity score matching, clinical characteristics of the study groups did not differ significantly. Prostate Imaging-Reporting & Data System (PI-RADS) distribution did not show a significant difference (p=0.51); PI-RADS ≥3 lesions were identified in 20/48 (42%) patients with indwelling catheters and in 18/50 (36%) patients without catheters. Among patients with a PI-RADS score ≥3, clinically significant prostate cancer (csPCa) was identified in 5/20 patients carrying catheters and 6/18 patients without catheters (p=0.152). A higher rate of any cancer was identified in patients without a catheter (67% vs. 35%, p=0.049). PSA >9.79 ng/ml predicted the finding of csPCa in patients carrying urinary catheters with PI-RADS ≥3 lesions.

conclusionsOur findings suggest no significant difference in mpMRI findings and csPCa rates for patients with and without indwelling urinary catheters. Patients carrying urinary catheters suspected to harbor csPCa based on an elevated PSA level should undergo further evaluation, including mpMRI and biopsies when necessary before benign prostatic hyperplasia treatment.

Identifiers

PMID40967185
PMCPMC12604916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.